EFTA
Search
Search
Entities
About
Settings
/
to search
Search
Search syntax help
Dataset
Set 1
Set 2
Set 3
Set 4
Set 5
Set 6
Set 7
Set 8
Set 9
Set 10
Set 11
Set 12
Sort
Relevance
Most pages
Most words
Dataset
Newest
Oldest
Status
All
Extracted
Failed
DOJ Status
All
Removed
Available
Date Range
Undated only
–
Page Count
–
Saved Searches
+
3 results for “
"Glybera"
”
Export
EFTA02387794
Set 11
2014-09-06
2p
845w
care companies. Pharmaceuticals are becoming more costly du= to increasingly smaller (personalized) markets (e.g.
Glybera
at $1.6M per =reatment) -- Hence the prospect of Androcyte therapies that apply to every
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02387794.pdf
Keyboard Shortcuts
/
Focus search
Esc
Blur input
O
Open PDF
←
→
Paginate
EFTA00363305
Set 9
2014-09-09
3p
1,069w
care companies. Pharmaceuticals are becoming more costly due to increasingly smaller (personalized) markets (e.g.
Glybera
at $1.6M per treatment) -- Hence the prospect of Androcyte therapies that apply to every
https://www.justice.gov/epstein/files/DataSet%209/EFTA00363305.pdf
EFTA00997325
Set 9
2014-09-25
4p
1,350w
care companies. Pharmaceuticals are becoming more costly due to increasingly smaller (personalized) markets (e.g.
Glybera
at $1.6M per treatment) -- Hence the prospect of Androcyte therapies that apply to every
https://www.justice.gov/epstein/files/DataSet%209/EFTA00997325.pdf
Results by Dataset
3 total
Set 9
2
Set 11
1
Corpus: 1990-03-17 – 2025-12-01
←
September 2014
→
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Undated
(150,429)
None
Light
Medium
Heavy